EVALUATION OF CORONARY-ARTERY DISEASE EXTENT USING 99TCM-SESTAMIBI - COMPARISON OF DIPYRIDAMOLE VERSUS EXERCISE AND OF PLANAR VERSUS TOMOGRAPHIC IMAGING

被引:8
作者
BISI, G
SCIAGRA, R
SANTORO, GM
BRIGANTI, V
LEONCINI, M
FAZZINI, PF
机构
[1] Nuclear Medicine Unit, Department of Clinical Pathophysiology, University of Florence, Florence
[2] Division of Cardiology, Careggi Hospital, Florence
关键词
D O I
10.1097/00006231-199311000-00003
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of this study was to compare the reliability of Tc-99m-sestamibi myocardial scintigraphy for the assessment of coronary artery disease extent using two different stresses (exercise and dipyridamole) and imaging techniques (planar versus single photon emission tomography, SPET) in a patient population of 20 subjects, all also studied with coronary angiography. The agreement of exercise and dipyridamole was good for the visual uptake score (planar kappa=0.71, SPET kappa=0.64) and for abnormal segment detection (planar and SPET both kappa=0.76). For the recognition of the individual diseased vessel, the results of exercise and dipyridamole planar scans were equal (sensitivity 49%, specificity 90%, accuracy 63%); those of exercise and dipyridamole SPET were also similar and were both better than the related planar data (sensitivity 79% and 74%, P<0.005 and <0.02, respectively, versus planar; specificity 95% and 100%; accuracy 85 and 83%, P<0.001 and <0.02 versus planar). Both stresses and imaging techniques were less sensitive in cases of mild (50 to 70%) obstructions. In conclusion, exercise and dipyridamole appear equally effective stresses for Tc-99m-sestamibi scintigraphy; with both of them, however, SPET allows significantly better results than planar imaging and therefore should be recommended.
引用
收藏
页码:946 / 954
页数:9
相关论文
共 21 条
[1]  
Gould K.L., Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. I. Physiologic basis and experimental validation, Am J Cardiol, 41, pp. 269-278, (1978)
[2]  
Gould K.L., Westcott R.J., Albro P.C., Hamilton G.W., Nonin¬vasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. II. Cardiac methodology and feasibility, Am J Cardiol, 41, pp. 279-287, (1978)
[3]  
Leppo J.A., Dipyridamole-thallium imaging: The lazy man's stress test, J Nucl Med, 30, pp. 281-287, (1989)
[4]  
Iskandrian A.S., Heo J., Askenase A., Segal B.L., Auerbach N., Dipyridamole cardiac imaging, Am Heart J, 115, pp. 432-443, (1990)
[5]  
Botvinick E.H., Dae M.W., Dipyridamole perfusion scintigraphy, Semin Nucl Med, 21, pp. 242-265, (1991)
[6]  
Leppo J.A., Boucher C.A., Okada R.D., Et al., Serial thallium- 201 myocardial imaging after dipyridamole infusion: Diagnostic utility in detecting coronary stenoses and relationship to regional wall motion, Circulation, 66, pp. 649-657, (1982)
[7]  
Leppo J., O'brien J., Rothendler J.A., Et al., Dipyridamole thallium scintigraphy in the prediction of future cardiac events after acute myocardial infarction, N Engl J Med, 310, pp. 101-118, (1984)
[8]  
Wackers F., Berman D.S., Maddahi J., Et al., Technetium- 99m hexakis 2-methoxyisobutyl isonitrile: Human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging, J Nucl Med, 30, pp. 301-311, (1989)
[9]  
Glover D.K., Okada R.D., Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole, Circulation, 81, pp. 628-636, (1990)
[10]  
Primeau M., Taillefer R., Essiambre R., Et al., Technetium 99m sestamibi myocardial perfusion imaging: Comparison between treadmill, dipyridamole and trans-oesophageal pacing 'stress' tests in normal subjects, Eur J Nucl Med, 18, pp. 247-251, (1991)